Eusol Biotech Co.,Ltd. (TPEX:6652)
Taiwan · Delayed Price · Currency is TWD 7.67
+0.48 (6.68%)
At close: Feb 11, 2026
Eusol Biotech Market Cap
Eusol Biotech has a market cap or net worth of 1.05 billion as of February 11, 2026. Its market cap has decreased by -1.67% in one year.
Market Cap
1.05B
Enterprise Value
725.11M
Revenue
370.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
7.67
Market Cap Chart
Since August 29, 2018, Eusol Biotech's market cap has decreased from 5.42B to 1.05B, a decrease of -80.63%. That is a compound annual growth rate of -19.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.05B | 29.78% |
| Dec 31, 2025 | 809.67M | -26.13% |
| Dec 31, 2024 | 1.10B | -15.43% |
| Dec 29, 2023 | 1.30B | 16.79% |
| Dec 30, 2022 | 1.11B | -45.27% |
| Dec 30, 2021 | 2.03B | -35.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enimmune | 1.44B |
| Meribank Biotech | 1.30B |
| GeneReach Biotechnology | 1.18B |
| Lukas Biomedical | 1.18B |
| Holy Stone Healthcare | 1.14B |
| Level Biotechnology | 1.07B |
| Taiwan Advance Bio-Pharmaceutical | 990.00M |
| TCI GENE | 986.90M |